This risk calculator requires only four clinical and three simple imaging parameters to assess the likelihood that a lipomatous tumour is an ALT, thereby determining whether molecular pathology testing is necessary for the biopsy or resection specimen. This evidence concerns the gene GPT and neoplasm.